Cartesian Therapeutics, Inc. — Director's Dealing 2017

Jun 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-06-16

Reporting Person: ZENNER PATRICK J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-16	Stock Option (Right to Buy)	$17.47	A	12820	Acquired	2027-06-15	Common Stock (12820)	Direct

Footnotes

F1: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.